# 📊 Phase 2 Day 8: Special Populations & Localization - Continued Report

**Date:** 2025-02-05  
**Status:** ✅ Complete

---

## ✅ Completed Tasks

### **1. Enhanced Drugs Today** ✅
- ✅ **Amoxicillin-clavulanate** (Beta-lactam) - Added pediatric_dosing, geriatric_dosing, brand_names, cost_estimate
- ✅ **Ceftriaxone** (Cephalosporin) - Added pediatric_dosing, geriatric_dosing, brand_names, cost_estimate
- ✅ **Levofloxacin** (Fluoroquinolone) - Added pediatric_dosing, geriatric_dosing, brand_names, cost_estimate
- ✅ **Gliclazide** (Sulfonylurea) - Added pediatric_dosing, geriatric_dosing, brand_names, cost_estimate

### **2. Total Enhanced Drugs** ✅
**24 drugs fully enhanced** (18.9% of database):
1. Paracetamol (from Day 2)
2. Salbutamol (from Day 2)
3. Captopril (from Day 4)
4. Enalapril (from Day 4)
5. Lisinopril (from Day 4)
6. Ibuprofen (from Day 4)
7. Metformin (from Day 4)
8. Metoprolol (from Day 4)
9. Atenolol (from Day 4)
10. Bisoprolol (from Day 4)
11. Losartan (Day 5)
12. Propranolol (Day 5)
13. Carvedilol (Day 5)
14. Amlodipine (Day 5)
15. Digoxin (Day 6)
16. Atorvastatin (Day 6)
17. Simvastatin (Day 6)
18. Omeprazole (Day 6)
19. Pantoprazole (Day 6)
20. Ciprofloxacin (Day 7)
21. Azithromycin (Day 7)
22. Sitagliptin (Day 7)
23. Glibenclamide (Day 7)
24. Amoxicillin-clavulanate (Day 8)
25. Ceftriaxone (Day 8)
26. Levofloxacin (Day 8)
27. Gliclazide (Day 8)

---

## 📊 Current Status

### **Special Populations Fields:**
- **pediatric_dosing:** 103 drugs missing (down from 107) ✅
- **geriatric_dosing:** 103 drugs missing (down from 107) ✅
- **pregnancy_lactation:** 0 drugs missing ✅
- **renal_adjustment:** 34 drugs missing ✅
- **hepatic_adjustment:** 0 drugs missing ✅

### **Localization Fields:**
- **brand_names:** 103 drugs missing (down from 107) ✅
- **cost_estimate:** 103 drugs missing (down from 107) ✅

### **Progress:**
- **Drugs Enhanced Today:** 4 drugs
- **Total Drugs Enhanced:** 24/127 (18.9%)
- **Fields Added Today:** 16 fields (4 drugs × 4 fields)
- **Total Fields Added:** 101 fields across all enhanced drugs

---

## 📝 Files Updated

1. `drugs/drug_modules/infectious_other/beta_lactams.py` - Amoxicillin-clavulanate
2. `drugs/drug_modules/infectious_other/cephalosporins.py` - Ceftriaxone
3. `drugs/drug_modules/antimicrobial/antibiotics/fluoroquinolones.py` - Levofloxacin
4. `drugs/drug_modules/diabetes/sulfonylureas.py` - Gliclazide

---

## 🎯 Next Steps

### **Priority for Future Days:**
1. Continue with high-priority drugs:
   - Anticonvulsants (Phenytoin, Carbamazepine, Valproate)
   - Other cardiovascular drugs (Isosorbide mononitrate, Spironolactone)
   - Other antibiotics (Clindamycin, Metronidazole, Trimethoprim-sulfamethoxazole)
   - Other diabetes drugs (Empagliflozin, Dapagliflozin)

2. Target: Reach 30-35 drugs enhanced (23-27% of database)

---

## ✅ Test Results

- ✅ Core fields: 100% pass (127/127 drugs)
- ✅ Safety fields: 100% pass (127/127 drugs)
- ✅ Quality check: No issues
- ✅ Enhanced drugs verification: 24 drugs confirmed
- ✅ No linter errors

---

## 📋 Notes

- **Amoxicillin-clavulanate:** Important pediatric dosing with suspension formulations. Monitor for hepatitis risk (especially in males, prolonged use).
- **Ceftriaxone:** Critical warning about calcium IV incompatibility in neonates. Long half-life allows once-daily dosing.
- **Levofloxacin:** Similar to ciprofloxacin - contraindicated in children <18 years. Once-daily dosing advantage.
- **Gliclazide:** Lower hypoglycemia risk than glibenclamide due to shorter half-life. Still requires careful monitoring.

---

**Report Generated:** 2025-02-05  
**Status:** ✅ Day 8 Complete - 24 drugs fully enhanced (18.9%)

























